| |
 |
|
|
Inventor: Muller-Peddinghaus; Reiner
Address: Bergisch Gladbach, DE
No. of patents: 22
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 6510658 |
System for fixing sun protection cloth |
January 28, 2003 |
| A system for fixing sun protection cloths to produce shade on projecting balconies of houses wherein two guiding elements extending parallel to each other and set at different heights are used, the lower guiding element being borne by stretching or retaining devices fixed to the balc |
| 6394693 |
Fixing clamp |
May 28, 2002 |
| A fixing clamp for a tensioning rope is proposed, where a clamping screw presses the tensioning rope against an abutment surface in friction-tight fashion. The abutment surface is formed by the bottom of metal bracket (10) bent in an approximately V or U shape and located in the mount (8 |
| 5597833 |
Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives |
January 28, 1997 |
| Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives are prepared by reacting correspondingly substituted phenols with quinolylmethyl halides or by reacting unsubstituted phenols with quinolylmethyl halides and subsequent alkylation. The substituted quinol-2-yl-methoxy-pheny |
| 5399698 |
Quinolin-2-yl-methoxybenzylhydroxyureas |
March 21, 1995 |
| The novel quinolin-2-yl-methoxybenzylhydroxyureas can be prepared by reaction of appropriate ketones with hydroxylamine and reduction of the ketoximes and subsequent reaction with isocyanates. The new substances can be employed as active substances in medicaments. |
| 5391747 |
Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphon-amides and -cyanamides, processes for the |
February 21, 1995 |
| A (quinolin-2-yl-methoxy) phenylacyl-sulphonamide or -cyanamide of the formula ##STR1## and physiologically acceptable salts thereof. The (quinolin-2-yl-methoxy)phenylacylsulphonamide or -cyanamide is useful as an active compound in medicaments, particularly as a lipoxygenase |
| 5391555 |
Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors |
February 21, 1995 |
| Described are methods for ameliorating symptoms associated with inflammatory bowel disease such as ulcerative colitis and Crohn's disease (regional enteritis) with four specific quinoline leukotriene synthesis inhibitors. |
| 5310744 |
Quinolylmethoxyphenyl-acetamides |
May 10, 1994 |
| Quinolylmethoxyphenyl-acetamides of the formula: ##STR1## in which A, B, D, E, G, L and M are hydrogen, hydroxyl, halogen, cyano, carboxyl, nitro, trifluoromethyl, trifluoromethoxy, alkyl, alkoxy or optionally substituted aryl;R.sub.1 represents optionally substituted cycloalkyl; and |
| 5292769 |
Substituted mandelic acid derivatives and their use in medicaments |
March 8, 1994 |
| Substituted mandelic acid derivatives can be prepared by reaction of glyoxylic esters with Grignard compounds. The substituted mandelic acid derivatives are suitable as active compounds in medicaments, in particular for medicaments which inhibit leukotriene synthesis. |
| 5288733 |
Quinolylmethoxyphenylacetic acid acylamides and ureas |
February 22, 1994 |
| Quinolylmethoxyphenylacetic acid acylamides and ureas can be prepared either by reacting corresponding carboxylic acids with amides or reacting corresponding amides with isocyanates or ureas. The quinolylmethoxyphenylacetic acid acylamides or ureas can be used as active compounds in |
| 5283252 |
Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives |
February 1, 1994 |
| Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives are prepared by reaction of halogenoacetoacetic acid esters with quinolylmethoxyphenylacetic acid thioamides, which are obtainable from corresponding amides with Lawesson's reagent. The substances can be employed in m |
| 5266578 |
Heterocyclically substituted quinolylmethoxy-phenylacetamides |
November 30, 1993 |
| Heterocyclically substituted quinolylmethoxyphenylacetamides are prepared by amidation of corresponding carboxylic acids. The compounds can be used in medicaments, in particular those having lipoxygenase-inhibiting action. |
| 5231103 |
Quinolin-2-yl-methoxybenzylhydroxyureas |
July 27, 1993 |
| The novel quinolin-2-yl-methoxybenzylhydroxyureas can be prepared by reaction of appropriate ketones with hydroxylamine and reduction of the ketoximes and subsequent reaction with isocyanates. The new substances can be employed as active substances in medicaments. |
| 5192771 |
(Quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents |
March 9, 1993 |
| For inhibiting lipoxygenzce, (quinolin-2-yl-methoxy) phenylacetic acid derivatives containing cyclic substituents of the formula ##STR1## in which A, Q, D, E, G, T and M are hydrogen or various radicals,R.sup.3 is halogen or an alkyl or phenyl radical, andR.sup.1 and R.sup.2 complete a c |
| 5179106 |
Substituted N-(quinolin-2-yl-methoxy) benzyl-sulphonylurea leukotriene synthesis inhibitors |
January 12, 1993 |
| Inhibiting leucotriene synthesis in patients with novel substituted N-(quinolin-2-yl-methoxy)benzylsulphonyl-urea of the formula ##STR1## in which A, B, D, E, G, K and M each independently is H, OH, halogen, CF.sub.3, OCF.sub.3, COOH, alkyl, alkoxy, alkoxycarbonyl or aryl,R.sup.1 is |
| 5126354 |
Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivat |
June 30, 1992 |
| Inhibiting leucotriene synthesis in patients with novel disubstituted (quinolin-3-yl-methoxy)phenylacetic acid derivatives of the formula ##STR1## in which A, B, D, E, G, K and M each independently is H, OH, halogen, CF.sub.3, OCF.sub.3, COOH, alkyl, alkoxycarbonyl or aryl,R.sup.1 is |
| 5120744 |
Substituted (quinolin-2-yl-methoxy)phenylthioureas |
June 9, 1992 |
| Substituted (quinolin-2-ylmethoxy)phenyl-thio-ureas of the formula ##STR1## in which A, B, D, E, G, K and Mrepresent hydrogen, hydroxyl, halogen, carboxyl, nitro, trifluoromethyl or trifluoromethoxy, orrepresent alkyl, alkoxy or alkoxycarbonyl, orrepresent aryl, which is optionally subst |
| 5091392 |
Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphon-amides and -cyanamides, processes for the |
February 25, 1992 |
| A quinolin-2-yl-methoxy)phenylacyl-sulphonamide or -cyanamide of the formula ##STR1## in which A, B, D, E, F and G are identical or different andrepresent hydrogen, hydroxyl, halogen, carboxyl, nitro, trifluoromethyl, trifluoromethoxy or a group of the formula --NH.sup.3 R.sup.4, in |
| 5045547 |
Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas and use the |
September 3, 1991 |
| Lipoxygenase-inhibiting and leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas of the formula ##STR1## and physiologically acceptable salts thereof. |
| 5013852 |
3-flavone carboxylic acid compounds |
May 7, 1991 |
| Flavone-3-carboxylic acid compounds corresponding to the Formula I: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 represent hydrogen, lower alkyl, halogen, hydroxy, or etherified or esterified hydroxy, and Z-R.sup.6 stands for a basically substituted alkoxy or amino |
| 4970215 |
Substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives and anti-allergic use thereo |
November 13, 1990 |
| Leucotriene synthesis inhibiting substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives of the formula ##STR1## R.sup.1 --represents a group of the formula ##STR2## wherein Y--represents a group of the formula ##STR3## Z--represents norbornyl, or represents a |
| 4929626 |
.alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters and lipoxygenase inhi |
May 29, 1990 |
| As lipoxygenase inhibitors, the novel .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid and esters thereof of the formula ##STR1## in which R.sup.1 - stands for hydrogen, alkyl, arylalkyl, aryl or- for a group of the formulawhereR.sup.3 - stands for hydrogen, alkyl, ary |
| 4886806 |
Flavone-3-carboxylic acids compounds and pharmaceutical compositions containing them |
December 12, 1989 |
| Falvone-3-carboxylic acid compounds corresponding to the Formula I: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 represent hydrogen, lower alkyl, halogen, hydroxy, or etherified or esterified hydroxy, and Z--R.sup.6 stands for a basically substituted alkoxy or amin |
|
|
|
